Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Taro Pharmaceutical USA Inc.
Current Parent Company: Sun Pharmaceuticals
Penalty: $67,643,000
Year: 2023
Date: March 9, 2023
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Mega-Scandal: Drug Pricing Abuses
Violation Description: Taro Pharmaceutical agreed to pay over $67 million to direct purchaser plaintiffs to settle litigation alleging it conspired to inflate the prices of generic drugs. The amount was subject to possible reduction but court documents did not specify by how much.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:16md2724
Case Name: In re: Generic Pharmaceuticals Pricing Antitrust Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: India
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.